Incyte
INCY
#1125
Rank
HK$153.50 B
Marketcap
HK$781.89
Share price
-1.02%
Change (1 day)
34.61%
Change (1 year)

Market capitalization of Incyte (INCY)

Market cap: HK$153.50 Billion

As of December 2025 Incyte has a market cap of HK$153.50 Billion. This makes Incyte the world's 1125th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Incyte from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$153.50 B48.25%
2024HK$103.54 B-5.79%
2023HK$109.90 B-21.28%
2022HK$139.61 B10.43%
2021HK$126.42 B-14.38%
2020HK$147.66 B0.44%
2019HK$147.01 B38.43%
2018HK$106.20 B-31.99%
2017HK$156.16 B6.61%
2016HK$146.47 B-6.64%
2015HK$156.89 B61.91%
2014HK$96.89 B51.43%
2013HK$63.98 B272.39%
2012HK$17.18 B16.69%
2011HK$14.72 B-7.32%
2010HK$15.88 B89.18%
2009HK$8.39 B195.1%
2008HK$2.84 B-57.04%
2007HK$6.62 B73.67%
2006HK$3.81 B10.2%
2005HK$3.46 B-46.3%
2004HK$6.44 B67.58%
2003HK$3.84 B61%
2002HK$2.38 B-76.39%
2001HK$10.11 B-20.61%
2000HK$12.74 B-5.36%
1999HK$13.46 B67.1%
1998HK$8.05 B-3.92%
1997HK$8.38 B101.56%
1996HK$4.16 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Incyte was reported to be:

HK$153.50 Billion
by Nasdaq info icon info icon
HK$153.50 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
HK$1.425 T 828.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$28.87 B-81.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$7.078 T 4,511.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.137 T 640.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
HK$6.30 B-95.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
HK$11.19 B-92.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$1.977 T 1,188.40%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
HK$4.05 B-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
HK$9.33 B-93.92%๐Ÿ‡บ๐Ÿ‡ธ USA